NTLA stock results show that Intellia Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
Articles
VIRI Stock Earnings: Virios Therapeutics Misses EPS for Q1 2024
VIRI stock results show that Virios Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
AMC Stock Falls as AMC Entertainment Loses Attendees
AMC stock is falling lower after posting a decline in both U.S. attendance and global attendance while remaining unprofitable. More
Is Roblox (RBLX) Stock on the Brink of Death? Lower Player Spending Might Say Yes.
Roblox just reported Q1 earnings, and its users are dialing back their spending. Here's why this is bad news for RBLX stock. More
Renewed Alphabet-HubSpot Deal Talks Thrust HUBS Stock Into the Spotlight
HubSpot stock is in the news Thursday as HUBS investors react to reports of an Alphabet takeover and a positive Q1 earnings report. More
Is the Stock Market on a Crash Course in 2024?
With stocks tumbling in April, alongside largely disappointing economic data, fears of a stock market crash are reaching a fever pitch. More
